Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Inci Alacacıoglu"'
Autor:
Murat Küçük, Mehmet Celal Öztürk, Boran Yavuz, Bişar Ergün, Mehmet Nuri Yakar, Bilgin Cömert, Ali Necati Gökmen, İnci Alacacıoğlu, Begüm Ergan
Publikováno v:
Türk Yoğun Bakim Derneği Dergisi, Vol 21, Iss 1, Pp 16-24 (2023)
Objective:With new treatment modalities, the overall survival of patients with hematological malignancies (HM) has increased over the years. However, intensive care unit (ICU) mortality is still high. This study aimed to evaluate the clinical charact
Externí odkaz:
https://doaj.org/article/05c01ac0e38b46299355485a905da7cd
Autor:
Ahmet Seyhanlı, Boran Yavuz, Zehra Akşit, Zeynep Yüce, Sermin Özkal, Oğuz Altungöz, Fatih Demirkan, İnci Alacacıoğlu, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 2, Pp 109-116 (2022)
Objective: Multiple myeloma (MM) is a malignant condition characterized by the accumulation of malignant plasma cells. Although MM remains incurable, the survival of MM patients has improved considerably due to the application of autologous stem cell
Externí odkaz:
https://doaj.org/article/a9f9a3e8d1444c2c9d9e8ff29832771c
Autor:
Tevfik Hatipoğlu, Esra Esmeray Sönmez, Xiaozhou Hu, Hongling Yuan, Ayça Erşen Danyeli, Ahmet Şeyhanlı, Tuğba Önal-Süzek, Weiwei Zhang, Burcu Akman, Aybüke Olgun, Sermin Özkal, İnci Alacacıoğlu, Mehmet Ali Özcan, Hua You, Can Küçük
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Follicular lymphoma (FL) is the second most frequent non-Hodgkin lymphoma accounting for 10-20% of all lymphomas in western countries. As a clinically heterogeneous cancer, FL occasionally undergoes histological transformation to more aggressive B ce
Externí odkaz:
https://doaj.org/article/a97d0c08e61d4d53a4a93208ea840177
Autor:
Serife Solmaz, Celal Acar, Ahmet Seyhanlı, Omur Gokmen Sevindik, Ozden Piskin, Mehmet Ali Ozcan, Fatih Demirkan, Bülent Undar, Inci Alacacioglu, Guner Hayri Ozsan
Publikováno v:
Indian Journal of Transplantation, Vol 14, Iss 1, Pp 57-62 (2020)
Introduction: High-dose chemotherapy (HDC) and autologous stem cell transplantation(ASCT) still remains in the treatment of myeloma patients even during the period of new agents. Materials and Methods: We analysed the prognostic affect of pretranspla
Externí odkaz:
https://doaj.org/article/d3fc096c721d4ec1a3550a2022a31539
Autor:
Esra Esmeray Sönmez, Tevfik Hatipoğlu, Deniz Kurşun, Xiaozhou Hu, Burcu Akman, Hongling Yuan, Ayça Erşen Danyeli, İnci Alacacıoğlu, Sermin Özkal, Aybüke Olgun, Taner Kemal Erdağ, Hua You, Can Küçük
Publikováno v:
Cells, Vol 11, Iss 21, p 3394 (2022)
Mantle cell lymphoma (MCL) is an aggressive B-cell non-Hodgkin lymphoma (NHL) subtype characterized by overexpression of CCND1 and SOX11 genes. It is generally associated with clinically poor outcomes despite recent improvements in therapeutic approa
Externí odkaz:
https://doaj.org/article/668765ab0f884b10aa23b3fd30d12de9
Autor:
Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran, Ali Eser, Tayfur Toptaş, Vildan Özkocaman, Handan Haydaroğlu Şahin, Esra Ermiş Turak, Ramazan Esen, Melda Cömert, Sevil Sadri, Müzeyyen Aslaner, Bahar Uncu Ulu, Abdullah Karakuş, Derya Selim Batut, İnci Alacacıoğlu, Demet Aydın, Atakan Tekinalp, Sinem Namdaroğlu, Funda Ceran
Publikováno v:
Turkish Journal of Hematology, Vol 36, Iss 4, Pp 230-237 (2019)
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total of 285 chronic ITP patient
Externí odkaz:
https://doaj.org/article/f62f596267fc4188a4b3ff19c7f174b1
Autor:
Süleyman Cem Adıyaman, İnci Alacacıoğlu, Ayça Ersen Danyeli, Doğuş Türkyılmaz, Ömür Gökmen Sevindik, Fatih Demirkan, Özden Pişkin, Mehmet Ali Özcan, Bülent Ündar, Şermin Özkal, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 36, Iss 2, Pp 81-87 (2019)
Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). The treatment of older NHL patients has always been a struggle; however, treatment statistics have begun showing favorable results similar to thos
Externí odkaz:
https://doaj.org/article/a052bd3670754c85b2d726bbebae4be3
Autor:
Şerife Solmaz Medeni, Doğus Türkyılmaz, Celal Acar, Ömür Gökmen Sevindik, Faize Yüksel, Özden Pişkin, Mehmet Ali Özcan, Fatih Demirkan, Bülent Ündar, İnci Alacacıoğlu, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Objective: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x106/kg CD34+ cells is preferred to achieve engraftment. Some
Externí odkaz:
https://doaj.org/article/3903f33454c340b9bbc990d2d2e4c0d0
Autor:
Serife Solmaz, Ozcan Uzun, Celal Acar, Omur Gokmen Sevindik, Ozden Piskin, Hayri Guner Ozsan, Fatih Demirkan, Bulent Undar, Ahmet Alacacioglu, Mehmet Ali Ozcan, Inci Alacacioglu
Publikováno v:
Journal of Laboratory Physicians, Vol 10, Iss 04, Pp 363-369 (2018)
BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. M
Externí odkaz:
https://doaj.org/article/9614468517bc47dc9a3cff5ebe6f7c96
Autor:
Nurhilal Büyükkurt, Guner Hayri Özsan, Sermin Özkal, Gülşah Seydaoğlu, İnci Alacacıoğlu, Mehmet Ali Özcan, Fatih Demirkan, Özden Pişkin, Bülent Ündar
Publikováno v:
Cukurova Medical Journal, Vol 42, Iss 3, Pp 499-506 (2017)
Amaç: Birçok faktör hematopoetik kök hücre (HKH) engraftmanını etkiler. Bu çalışmada hematolojik kanseri olan hastalarda kemik iliğindeki myelofibrozis ve anjiogenezisin engraftman üzerine etkisi araştırılmıştır.Gereç ve Yöntem: O
Externí odkaz:
https://doaj.org/article/469bcc27f93e431aafcbf932258c804b